Citius Pharmaceuticals, Inc. (CTXR) vs IRIDEX Corporation (IRIX)
A side-by-side comparison of Citius Pharmaceuticals, Inc. and IRIDEX Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CTXR
Citius Pharmaceuticals, Inc.
$0.51HealthcareDelayed quote: Oct 6, 2026, 11:03 AM EDT
IRIX
IRIDEX Corporation
$0.73HealthcareDelayed quote: Oct 6, 2026, 11:00 AM EDT
Total return — CTXR vs IRIX
growth of $100 · dividends reinvested · last 10yCTXR -99.8% (-46.2%/yr)IRIX -95.2% (-26.2%/yr)IRIX compounded faster over this window
Log scale — wide-divergence pair
CTXR IRIX
CTXR vs IRIX: by the numbers
- •CTXR is the larger company ($14M vs $13M market cap).
- •Both run net losses; IRIX's is the smaller (-6.88% vs -651.27% net margin).
Metrics side by side
Valuation
| Metric | CTXR | IRIX |
|---|---|---|
| P/S ratio | 1.97 | 0.25 |
| P/B ratio | 0.21 | N/A |
Profitability
| Metric | CTXR | IRIX |
|---|---|---|
| Gross margin | 0.00% | 36.23% |
| Operating margin | 0.00% | -5.39% |
| Net margin | -651.27% | -6.88% |
| ROE | -69.47% | -97.47% |
| ROIC | -67.62% | -19.53% |
Growth (annualized)
| Metric | CTXR | IRIX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -0.57% |
| Total return CAGR (5Y) | -60.04% | -38.13% |
Frequently asked
- How have CTXR and IRIX total returns compared?
- Over the past 10 years, CTXR delivered -46.34% and IRIX delivered -26.14% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.